HeartBeam Snags New Patent For 12-Lead ECG Smartwatch-Based Monitor To Detect Heart Attacks

HeartBeam Snags New Patent For 12-Lead ECG Smartwatch-Based Monitor To Detect Heart Attacks
  • HeartBeam Inc BEAT announced that its patent for a 12-lead electrocardiogram (ECG) smartwatch-based monitor intended to detect heart attacks and complex cardiac arrhythmias was allowed by the United States Patent and Trademark Office (USPTO). 
  • The company says that currently available wearables cannot provide a 12-lead ECG for heart attack detection, complex arrhythmia monitoring, or other cardiac disorders.
  •  HeartBeam's latest patent further expands on the company's anytime, anywhere capabilities.
  • "The breakthrough inventions protected by this patent enable our proprietary 3D ECG technology to be built into a smartwatch, eliminating the need for a dedicated ECG device while offering a 12-lead ECG capability enabling heart attack and complex arrhythmia detection," said HeartBeam CEO and Founder Branislav Vajdic.
  • Recently, HeartBeam shares jumped 75% after its patent for a 12-lead electrocardiogram patch monitor intended to detect acute coronary syndrome and cardiac arrhythmia, which the USPTO issued.
  • Price Action: BEAT shares are down 1.40% at $3.65 on the last check Wednesday.
Posted In: BriefsNewsPenny StocksHealth CareMoversTrading IdeasGeneral